Prospective Study of White Blood Cells

Quell Therapeutics Limited10 enrolled

Overview

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Autoimmune Diseases Inflammation Rejection; Transplant, Liver

Interventions

White blood cell and blood collectionOTHER

Mononucleocytes will be collected via apheresis

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions.

Locations (1)

Quell Investigator Site 01

London, United Kingdom

RECRUITING

Outcomes

Primary Outcomes

WBC characterisation to support the development of engineered regulatory T cells.

number, type and function of white blood cells in healthy controls and in patients

Time frame: 5 years

Central Contacts

Gareth Wright

CONTACT

+4(0)2070969012 contact@quell-tx.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.